Have a personal or library account? Click to login
Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols Cover

Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols

Acta Pharmaceutica
Volume 69 (2019): Issue 1 (March 2019)
By: Saima Sattar,  Mobasher Ahmad,  Hamid Saeed,  Zikria Saleem,  Zeeshan Danish and  Muhammad Akhlaq  
Open Access
|Dec 2018
DOI: https://doi.org/10.2478/acph-2019-0002 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 87 - 97
Accepted on: Jul 16, 2018
Published on: Dec 7, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ovarian cancer,
carboplatin plus paclitaxel,
topotecan,
bevacizumab,
docetaxel
Related subjects:
Pharmacy,
Pharmacy, other

© 2018 Saima Sattar, Mobasher Ahmad, Hamid Saeed, Zikria Saleem, Zeeshan Danish, Muhammad Akhlaq, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 1 (March 2019)Next article